TipRanks
Agilent (IT:1A)
:1A
Italy Market
1A
Agilent
RESEARCH TOOLSreports

Agilent (1A) Stock Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

1A Analyst Ratings

Strong Buy
14Ratings
Strong Buy
11 Buy
3 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Agilent
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1A Stock 12 Month Forecast

Average Price Target

€163.06
▲(22.97% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Agilent in the last 3 months. The average price target is €163.06 with a high forecast of €174.51 and a low forecast of €133.55. The average price target represents a 22.97% change from the last price of €132.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"96":"€96","175":"€175","115.75":"€115.8","135.5":"€135.5","155.25":"€155.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":174.5085706,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€174.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":163.0612153857143,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€163.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":133.5524775,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€133.55</span>\n  </div></div>","useHTML":true}}],"tickPositions":[96,115.75,135.5,155.25,175],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,151.119,152.91819773846154,154.7173954769231,156.51659321538463,158.31579095384615,160.1149886923077,161.91418643076923,163.71338416923078,165.51258190769232,167.31177964615387,169.1109773846154,170.91017512307693,172.70937286153847,{"y":174.5085706,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,151.119,152.03763195274726,152.9562639054945,153.87489585824176,154.79352781098902,155.71215976373625,156.63079171648351,157.54942366923078,158.46805562197804,159.38668757472527,160.30531952747253,161.2239514802198,162.14258343296703,{"y":163.0612153857143,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,151.119,149.76772903846154,148.41645807692308,147.06518711538462,145.71391615384616,144.3626451923077,143.01137423076923,141.66010326923077,140.3088323076923,138.95756134615385,137.6062903846154,136.25501942307693,134.90374846153847,{"y":133.5524775,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":112.285,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.108,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.978,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.838,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.376,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.504,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.753,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.129,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.506,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":118.119,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":118.219,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":129.802,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.119,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€174.51Average Price Target€163.06Lowest Price Target€133.55
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on IT:1A
Eve Burstein
Bernstein
Bernstein
€160.26
Buy
20.86%
Upside
Assigned
10/19/26
Bernstein Reaffirms Their Buy Rating on Agilent (A)
UBS Analyst forecast on IT:1A
Doug Schenkel
UBS
UBS
€160.26
Hold
20.86%
Upside
Reiterated
10/14/26
UBS Remains a Hold on Agilent (A)
TD Cowen Analyst forecast on IT:1A
Daniel Brennan
TD Cowen
TD Cowen
€160.26→€174.51
Buy
31.61%
Upside
Reiterated
10/13/26
Agilent price target raised to $196 from $180 at TD CowenAgilent price target raised to $196 from $180 at TD Cowen
Morgan Stanley Analyst forecast on IT:1A
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
€155.81→€169.17
Buy
27.58%
Upside
Assigned
10/13/26
Agilent price target raised to $190 from $175 at Morgan StanleyAgilent price target raised to $190 from $175 at Morgan Stanley
Bank of America Securities Analyst forecast on IT:1A
Michael Ryskin
Bank of America Securities
Bank of America Securities
€160.26→€169.17
Buy
27.58%
Upside
Reiterated
10/13/26
Analysts' Top Healthcare Picks: Agilent (A), Guardant Health (GH)
Barclays Analyst forecast on IT:1A
Luke Sergott
Barclays
Barclays
€155.81→€173.62
Buy
30.93%
Upside
Reiterated
10/07/26
Barclays Sticks to Their Buy Rating for Agilent (A)
Goldman Sachs Analyst forecast on IT:1A
Evie Koslosky
Goldman Sachs
Goldman Sachs
€155.81→€164.71
Buy
24.22%
Upside
Reiterated
09/20/26
Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Ascendis Pharma (ASND)
Jefferies Analyst forecast on IT:1A
John Dunigan
Jefferies
Jefferies
€161.15
Hold
21.53%
Upside
Reiterated
09/17/26
Analysts Conflicted on These Healthcare Names: Agilent (NYSE: A) and Aquestive Therapeutics (NASDAQ: AQST)
Stifel Nicolaus Analyst forecast on IT:1A
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
€160.26
Buy
20.86%
Upside
Reiterated
08/30/26
Stifel Nicolaus Reaffirms Their Buy Rating on Agilent (A)
Piper Sandler Analyst forecast on IT:1A
David Westenberg
Piper Sandler
Piper Sandler
€133.55
Hold
0.72%
Upside
Reiterated
08/27/26
Piper Sandler Sticks to Its Hold Rating for Agilent (A)
J.P. Morgan Analyst forecast on IT:1A
Casey Woodring
J.P. Morgan
J.P. Morgan
€160.26→€169.17
Buy
27.58%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $180 at JPMorganAgilent price target raised to $190 from $180 at JPMorgan
Evercore ISI Analyst forecast on IT:1A
Vijay Kumar
Evercore ISI
Evercore ISI
€131.77→€153.14
Buy
15.49%
Upside
Reiterated
08/27/26
Agilent price target raised to $172 from $148 at Evercore ISIAgilent price target raised to $172 from $148 at Evercore ISI
Citi Analyst forecast on IT:1A
Patrick B Donnelly
Citi
Citi
€164.71→€169.17
Buy
27.58%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $185 at CitiAgilent price target raised to $190 from $185 at Citi
RBC Capital Analyst forecast on IT:1A
Dan Leonard
RBC Capital
RBC Capital
€138→€164.71
Buy
24.22%
Upside
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME), Revolution Medicines (NASDAQ: RVMD) and Agilent (NYSE: A)
HSBC Analyst forecast on IT:1A
Sidharth Sahoo
HSBC
HSBC
€160.26→€146.91
Buy
10.79%
Upside
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on IT:1A
Eve Burstein
Bernstein
Bernstein
€160.26
Buy
20.86%
Upside
Assigned
10/19/26
Bernstein Reaffirms Their Buy Rating on Agilent (A)
UBS Analyst forecast on IT:1A
Doug Schenkel
UBS
UBS
€160.26
Hold
20.86%
Upside
Reiterated
10/14/26
UBS Remains a Hold on Agilent (A)
TD Cowen Analyst forecast on IT:1A
Daniel Brennan
TD Cowen
TD Cowen
€160.26→€174.51
Buy
31.61%
Upside
Reiterated
10/13/26
Agilent price target raised to $196 from $180 at TD CowenAgilent price target raised to $196 from $180 at TD Cowen
Morgan Stanley Analyst forecast on IT:1A
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
€155.81→€169.17
Buy
27.58%
Upside
Assigned
10/13/26
Agilent price target raised to $190 from $175 at Morgan StanleyAgilent price target raised to $190 from $175 at Morgan Stanley
Bank of America Securities Analyst forecast on IT:1A
Michael Ryskin
Bank of America Securities
Bank of America Securities
€160.26→€169.17
Buy
27.58%
Upside
Reiterated
10/13/26
Analysts' Top Healthcare Picks: Agilent (A), Guardant Health (GH)
Barclays Analyst forecast on IT:1A
Luke Sergott
Barclays
Barclays
€155.81→€173.62
Buy
30.93%
Upside
Reiterated
10/07/26
Barclays Sticks to Their Buy Rating for Agilent (A)
Goldman Sachs Analyst forecast on IT:1A
Evie Koslosky
Goldman Sachs
Goldman Sachs
€155.81→€164.71
Buy
24.22%
Upside
Reiterated
09/20/26
Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Ascendis Pharma (ASND)
Jefferies Analyst forecast on IT:1A
John Dunigan
Jefferies
Jefferies
€161.15
Hold
21.53%
Upside
Reiterated
09/17/26
Analysts Conflicted on These Healthcare Names: Agilent (NYSE: A) and Aquestive Therapeutics (NASDAQ: AQST)
Stifel Nicolaus Analyst forecast on IT:1A
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
€160.26
Buy
20.86%
Upside
Reiterated
08/30/26
Stifel Nicolaus Reaffirms Their Buy Rating on Agilent (A)
Piper Sandler Analyst forecast on IT:1A
David Westenberg
Piper Sandler
Piper Sandler
€133.55
Hold
0.72%
Upside
Reiterated
08/27/26
Piper Sandler Sticks to Its Hold Rating for Agilent (A)
J.P. Morgan Analyst forecast on IT:1A
Casey Woodring
J.P. Morgan
J.P. Morgan
€160.26→€169.17
Buy
27.58%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $180 at JPMorganAgilent price target raised to $190 from $180 at JPMorgan
Evercore ISI Analyst forecast on IT:1A
Vijay Kumar
Evercore ISI
Evercore ISI
€131.77→€153.14
Buy
15.49%
Upside
Reiterated
08/27/26
Agilent price target raised to $172 from $148 at Evercore ISIAgilent price target raised to $172 from $148 at Evercore ISI
Citi Analyst forecast on IT:1A
Patrick B Donnelly
Citi
Citi
€164.71→€169.17
Buy
27.58%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $185 at CitiAgilent price target raised to $190 from $185 at Citi
RBC Capital Analyst forecast on IT:1A
Dan Leonard
RBC Capital
RBC Capital
€138→€164.71
Buy
24.22%
Upside
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME), Revolution Medicines (NASDAQ: RVMD) and Agilent (NYSE: A)
HSBC Analyst forecast on IT:1A
Sidharth Sahoo
HSBC
HSBC
€160.26→€146.91
Buy
10.79%
Upside
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
SIBNSI-Bone
IMUXImmunic
MDWDMediwound
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Agilent

3 Months
Dan LeonardRBC Capital
Success Rate
19/28 ratings generated profit
68%
Average Return
+5.58%
Copying Dan Leonard's trades and holding each position for 3 Months would result in 67.86% of your transactions generating a profit, with an average return of +5.58% per trade.
1 Year
Dan LeonardRBC Capital
Success Rate
23/28 ratings generated profit
82%
Average Return
+25.55%
Copying Dan Leonard's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +25.55% per trade.
2 Years
Patrick B DonnellyCiti
Success Rate
18/21 ratings generated profit
86%
Average Return
+25.19%
Copying Patrick B Donnelly's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +25.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1A Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
2
2
1
0
0
Buy
15
15
20
21
26
Hold
2
3
4
7
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
20
25
28
33
In the current month, 1A has received 26 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. 1A average Analyst price target in the past 3 months is 163.06.
Each month's total comprises the sum of three months' worth of ratings.

1A Financial Forecast

1A Earnings Forecast

Next quarter’s earnings estimate for 1A is €1.54 with a range of €1.52 to €1.55. The previous quarter’s EPS was €1.44. 1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1A has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1A is €1.54 with a range of €1.52 to €1.55. The previous quarter’s EPS was €1.44. 1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1A has Performed in-line its overall industry.

1A Sales Forecast

Next quarter’s sales forecast for 1A is €1.77B with a range of €1.76B to €1.78B. The previous quarter’s sales results were €1.67B. 1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1A has Performed in-line its overall industry.
Next quarter’s sales forecast for 1A is €1.77B with a range of €1.76B to €1.78B. The previous quarter’s sales results were €1.67B. 1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1A has Performed in-line its overall industry.

1A Stock Forecast FAQ

What is IT:1A’s average 12-month price target, according to analysts?
Based on analyst ratings, Agilent’s 12-month average price target is 163.06.
    What is IT:1A’s upside potential, based on the analysts’ average price target?
    Agilent has 22.97% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Agilent a Buy, Sell or Hold?
          Agilent has a consensus rating of Strong Buy, which is based on 11 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Agilent’s share price target?
            The average share price target for Agilent is 163.06. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €174.51 ,and the lowest forecast is €133.55. The average share price target represents 22.97% Increase from the current price of €132.6.
              What do analysts say about Agilent?
              Agilent’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of Agilent?
                To buy shares of IT:1A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.